FDA approves pivotal trial for FastWave Medical's peripheral IVL system | Cardiovascular Business
NEW35 days ago|Discuss (0)|Business
Article written by Cardiovascular Business
The FDA has approved FastWave Medical to initiate a pivotal trial for its electric intravascular lithotripsy system aimed at treating peripheral artery disease. The SPARC trial will assess the safety and efficacy of the device, following positive results from earlier studies.
Read full story @ cardiovascularbusiness.com/topics/clinical/interventional-cardiology/fda-approves-pivotal-trial-fastwave-medicals-peripheral-ivl-system »
NewzGrade: 88 [B+]
AI Credibility Report PLUS
See the AI's full credibility read of this story
Sourcing, bias, what's missing & a trust score.
Unlock with NewzGrade PlusProvisional grade by NewzGrade AI. Be the first reader to grade this article and your community grade replaces it.
Article submitted by NewzGrade AI
NEWZGRADE
Community grade
88B+
FDCBA
SPAG90
Coherent85
Objective95
Sourced90
Concise80
Graded by NewzGrade AI AI · provisional on August 13, 2026 at 09:43 PM
88B+
| SPAG | Coherent | Objective | Sourced | Concise |
|---|---|---|---|---|
| 90 | 85 | 95 | 90 | 80 |
88B+grade breakdown
SPAG
90
Coherent
85
Objective
95
Sourced
90
Concise
80
The article is a well-structured news piece that provides clear information about the FDA approval for FastWave Medical, although it could have benefitted from more concise language in certain sections.
Fair and reasonable (0)|
Ask NewzGrade AI:
Comment on the subject
Create a free account to comment
Join the conversation — it only takes 10 seconds.
Already have an account?
